Advisor Group’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Advisor Group’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$96K	Buy	6,600 +2,000	+43%	+$29.2K	﹤0.01%	2974
2019 Q3	$69K	Hold	4,600	–	–	﹤0.01%	3172
2019 Q2	$61K	Buy	4,600 +900	+24%	+$10.9K	﹤0.01%	3226
2019 Q1	$48K	Sell	3,700 -1,000	-21%	-$14.6K	﹤0.01%	3421
2018 Q4	$69K	Buy	4,700 +1,710	+57%	+$27.9K	﹤0.01%	2961
2018 Q3	$53K	Buy	+2,990	New	+$51.8K	﹤0.01%	3247
2017 Q4	–	Sell	-300	Closed	-$11K	–	5111
2017 Q3	$11K	Buy	+300	New	+$11.2K	﹤0.01%	3928

Other funds holding OPNT

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Advisor Group's OPNT Position: Q4 2019 in Review

Advisor Group increased its Opiant Pharmaceuticals, Inc. Common Stock (OPNT) stake by 43% in Q4 2019, buying an estimated $29.2K and bringing the position to 6,600 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #2974.

Advisor Group first reported a position in OPNT in Q3 2017 and has held it in 7 quarters since. 28 funds tracked by Wall St. Rank hold OPNT as of Q4 2019.

Advisor Group held 6,600 shares of Opiant Pharmaceuticals, Inc. Common Stock worth $96K as of Q4 2019.
Advisor Group bought 2,000 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $29.2K.
Opiant Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2974 holding.
Advisor Group first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2017 and has held it in 7 quarters since.
28 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.